How Targeted Cancer Therapies Are Driving the MUC1 Antibody Market Growth According to a newly published market research report by 24LifeSciences, global MUC1 Antibody market is valued at USD 450 million in 2026 and is projected to reach USD 1,066 million by 2034, growing at a compound annual growth rate (CAGR) of 13.4% during the forecast period. MUC1 Antibodies are specialized immunoglobulins targeting Mucin 1, a transmembrane glycoprotein overexpressed in multiple carcinomas including breast, pancreatic, and ovarian cancers. These antibodies enable detection through techniques such as flow cytometry, ELISA, and immunohistochemistry, playing critical roles in cancer research, diagnostics, and therapeutic development. With breast cancer alone accounting for 2.3 million new cases globally in 2022 according to WHO data, the established importance of MUC1 as a biomarker continues to drive market expansion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3018/muc-antibody-market-market

Leading Players Driving Growth in the Global Cell Detachment and Dissociation Solution Market According to a newly published market research report by 24LifeSciences, global cell detachment and dissociation solution market is valued at USD 547.8 million in 2026 and is projected to reach USD 882.4 million by 2034, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. Cell detachment and dissociation solutions are essential reagents in cell culture workflows, designed to effectively separate adherent cells from culture surfaces and dissociate them into viable single-cell suspensions. These solutions are critically important for numerous applications including cell harvesting, subculturing, cell-based assays, flow cytometry, and bioproduction processes. The market is primarily categorized into enzyme-based solutions such as trypsin and collagenase, and non-enzymatic alternatives that utilize chelating agents, each offering distinct advantages for specific cell types and research requirements. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9791/cell-detachment-and-dissociation-solution-market

What Is the Future of the Hematology Analyzer Market? Key Growth Drivers & Insights According to a newly published market research report by 24LifeSciences, global hematology analyzer market value is at USD 3.14 billion in 2026 and is projected to reach USD 4.20 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period. Hematology analyzers are sophisticated computerized instruments that perform complete blood counts (CBC) by automatically quantifying and characterizing blood cells using technologies like impedance, flow cytometry, and fluorescent flow cytometry. These systems provide critical diagnostic measurements for red blood cells, white blood cells with differentials, platelets, hemoglobin, and hematocrit, forming the backbone of modern clinical diagnostics for conditions ranging from anemia and infections to leukemia and other blood disorders. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7614/hematology-analyzer-market